SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: drtom1234 who wrote (38488)1/6/2017 11:29:50 PM
From: stockdoc77  Read Replies (3) of 63291
 
It might, it might not. How would they go about negotiating that and how long would that take? I do in fact think that Vmab and Emab cannot be sold for much, they may some day have value, but in the present circumstance I don't see any prospect of a bidding war. To fully fund a go it alone strategy would require 150 million at a minimum IMO, and to get that from a raise is the only way Venbio can put together that much money in a short period of time, which does not materially delay 132 filing for AA. Venbio has not said or done anything that suggests to me they are interested in a partnership. If they were, they would have said on the call that in addition to ferreting out whether 132 was "real", they would look at all the term sheets and the ongoing negotiations and rapidly conclude the best deal possible. The reason I'm pretty certain they intend to go it alone is because it's a case of the dog that didn't bark. It tells me something. And going it alone to me, means a raise.
This strategy is high reward, but also high risk. If IMMU does go it alone and the FDA does not grant AA, the company will be in a bind, perhaps resulting in a partnership at that time, but not before the stock has some major turbulence.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News